electroCore, Inc.
NASDAQ:ECORMedical - Devices
-$0.50 today
- Market cap
- $71.13M
- Beta
- 0.87
- P/E (TTM)
- -4.8
- EPS (TTM)
- -$1.72
Volume 0.06M
Average 0.11M
ECOR Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
electroCore, Inc.NASDAQ: ECOR
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $47K fell 75.8% year over year, behind the +24.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 96.0% from the prior quarter. Over 3 fiscal years it compounded at +45.1% a year.
Context
- Depreciation & amortization amounted to 5.2% of revenue in FY2025, up 0.2 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -75.8% toward the trailing-twelve-month pace of +24.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 1.68M USD
- Year-over-year change
- +33.1%
- 4-year CAGR
- +44.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.68M | +33.1% |
| FY2024 | 2024-12-31 | 1.26M | +22.7% |
| FY2023 | 2023-12-31 | 1.03M | +87.0% |
| FY2022 | 2022-12-31 | 548K | +43.5% |
| FY2021 | 2021-12-31 | 382K | — |
Depreciation & Amortization vs competitors
How ECOR compares with its peers on the latest reported figures
- ECOR's LTM Mar 2026 depreciation & amortization of $1.53M is the 2nd largest of the 6 companies compared; the peer median is $0.
- Its year-over-year change of +24.3% is the 3rd highest of 4, against a peer median of +76.4%.
- Depreciation & amortization amounts to 4.4% of revenue for ECOR, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2M | +76.4% | +53.9% | 4.9% | |
| LTM Mar 2026 | $1.53M | +24.3% | +45.1% | 4.4% | |
| LTM Mar 2026 | $2K | +100.0% | -30.7% | 0.1% | |
| LTM Dec 2025 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding ECOR) | $0 | +76.4% | +11.6% | 0.1% | |
Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (17.22M) | (22.16M) | (18.83M) | (11.89M) | (13.97M) |
| Depreciation & Amortization | 382K | 548K | 1.03M | 1.26M | 1.68M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 3.3M | 2.68M | 1.7M | 1.87M | 1.93M |
| Change in Working Capital | 1.63M | 2.04M | 815K | 1.76M | 1.33M |
| Accounts Receivables | (217K) | 37K | (262K) | (710K) | (142K) |
| Inventory | 371K | 296K | 96K | 713K | 16K |
| Accounts Payables | 464K | 1.19M | 35K | 1.05M | 2.45M |
| Other Working Capital | 1.01M | 519K | 946K | 708K | (999K) |
| Other Non-Cash Items | (1.72M) | 244K | 628K | 51K | 849K |
| Operating Cash Flow | (13.63M) | (16.65M) | (14.67M) | (6.95M) | (8.19M) |
| Capital Expenditures | 0 | 0 | (206K) | 0 | (66K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (5.08M) | 0 | 0 | (8.52M) | 3.94M |
| Sales of Investments | 23.3M | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 18.22M | 0 | (206K) | (8.52M) | 3.88M |
| Debt Repayment | 0 | 0 | 0 | 0 | 7.41M |
| Common Stock Issued | 25.68M | 0 | 8.14M | 8.3M | 222K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | (657K) | 139K | 0 |
| Financing Cash Flow | 25.68M | 0 | 7.49M | 8.44M | 7.63M |
| Effect of Forex Changes | 175K | (82K) | 6K | 147K | 18K |
| Net Change in Cash | 30.45M | (16.73M) | (7.38M) | (6.88M) | 3.34M |
| Free Cash Flow | (13.63M) | (16.65M) | (14.87M) | (6.95M) | (8.25M) |
electroCore, Inc.
NASDAQ:ECOR
Intrinsic Alpha fair value
Locked
Current Price
$7.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.